fbpx Skip to main content

BioCommunique Article

Bringing you the latest life science investing news and financial headlines.

Conatus Merges with Histogen; Scripps Receives $50M from Bill & Melinda Gates Foundation; Sorrento and Celularity Fight the Coronavirus

  • 2020-01-30T22:32:00.000+0000
  • California
  • Author: Lauren Panetta

1/29/20 – Bluestar Genomics
Bluestar Genomics’ Breakthrough Study Highlights Promising Data for Multi-Cancer Detection From a Single Blood Draw

1/29/19 – BioSpace
In a Strategic Realignment, Conatus Pharma Merges with Histogen

1/29/20 – Sorrento Therapeutics
Sorrento and Celularity to Initiate Emergency Allogeneic Natural Killer (NK) Cell Therapy Development for Coronavirus Infection

1/29/20 – Trovagene
Trovagene Receives Approximately $1.45 Million From Exercise of Warrants

1/29/20 – FierceBiotech
Racing Blueprint, Lilly Drug Gets Priority Review

1/29/20 – Endpoints
Ionis/Akcea's Pfizer-Partnered Antisense Drug Shows Promise in Study, with Implications for Arrowhead RNAi Asset — Analysts

1/28/20 – UC San Diego
Stem Cells, CRISPR and Gene Sequencing Technology are Basis of New Brain Cancer Model

1/28/20 – The San Diego Union-Tribune
Bill & Melinda Gates Foundation Gives Scripps Research $50M to Fight Deadly Diseases

1/28/20 – Gilead
European Medicines Agency Validates Kite’s Marketing Application for Company’s Second CAR T Cell Therapy

1/28/20 – Alector
Alector Announces Initiation of Phase 1b Study of AL003 in Alzheimer’s Disease Patients

1/27/20 – Salk
Salk Institute Welcomes New Trustees Larry Jennings, Jr., and Timothy Schoen

1/27/20 – FierceBiotech
Verily Nets Irregular Pulse Clearance for its Clinical Study Smartwatch

1/27/20 – Adverum
Adverum Biotechnologies Moves to New Headquarters and Expands Laboratory Space in Redwood City, CA

1/26/20 – The San Diego Union-Tribune
True Blood? In the Shadow of Theranos, Truvian Revives Dream of Low-Cost Blood Tests

1/24/20 – FierceBiotech
PwC Report Sees Pharma-Biotech Deals 'To Be Extremely Active in 2020'

1/23/2020 – FierceBiotech
Deloitte to Build Airborne Medical Delivery Program in San Diego

1/23/20 – Gilead
Gilead Assessing Ebola Drug as Possible Coronavirus Treatment

1/15/20 – Ultragenyx
GeneTx and Ultragenyx Announce Investigational New Drug (IND) Application Active for GTX-102 in Patients with Angelman Syndrome